Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP269891.RAzqg7uO1sDouNU3CLkqPGcRVu5RmHXE0r5MCeFE95HOg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP269891.RAzqg7uO1sDouNU3CLkqPGcRVu5RmHXE0r5MCeFE95HOg130_assertion type Assertion NP269891.RAzqg7uO1sDouNU3CLkqPGcRVu5RmHXE0r5MCeFE95HOg130_head.
- NP269891.RAzqg7uO1sDouNU3CLkqPGcRVu5RmHXE0r5MCeFE95HOg130_assertion description "[In particular, these include significantly reduced expression levels of three matrix metallopeptidases (MMP1, MMP3, MMP16), follistatin, and STAT1, and significantly increased expression levels of fibroblast growth factors (FGF9, FGF11), a number of collagen genes and other ECM genes in DD patient samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP269891.RAzqg7uO1sDouNU3CLkqPGcRVu5RmHXE0r5MCeFE95HOg130_provenance.
- NP269891.RAzqg7uO1sDouNU3CLkqPGcRVu5RmHXE0r5MCeFE95HOg130_assertion evidence source_evidence_literature NP269891.RAzqg7uO1sDouNU3CLkqPGcRVu5RmHXE0r5MCeFE95HOg130_provenance.
- NP269891.RAzqg7uO1sDouNU3CLkqPGcRVu5RmHXE0r5MCeFE95HOg130_assertion SIO_000772 23554969 NP269891.RAzqg7uO1sDouNU3CLkqPGcRVu5RmHXE0r5MCeFE95HOg130_provenance.
- NP269891.RAzqg7uO1sDouNU3CLkqPGcRVu5RmHXE0r5MCeFE95HOg130_assertion wasDerivedFrom befree-20140225 NP269891.RAzqg7uO1sDouNU3CLkqPGcRVu5RmHXE0r5MCeFE95HOg130_provenance.
- NP269891.RAzqg7uO1sDouNU3CLkqPGcRVu5RmHXE0r5MCeFE95HOg130_assertion wasGeneratedBy ECO_0000203 NP269891.RAzqg7uO1sDouNU3CLkqPGcRVu5RmHXE0r5MCeFE95HOg130_provenance.